Glucagon-like peptide-1 receptor expression on human eosinophils and its regulation of eosinophil activation

Patrick Mitchell, B Salter, John-Paul Oliveria, Amani I El-Gammal, Tworek D, Steven G Smith, Roma Sehmi, Gail Gauvreau, M Butler, Paul O'Byrne

Research output: Contribution to journalArticlepeer-review

Abstract

BACKGROUND:
Glucagon-like peptide-1 (GLP-1) and its receptor are part of the incretin family of hormones that regulate glucose metabolism. GLP-1 also has immune modulatory roles.

OBJECTIVES:
To measure the expression of the GLP-1 receptor (GLP-1R) on eosinophils and neutrophils in normal and asthmatic subjects and evaluate effects of a GLP-1 analog on eosinophil function.

METHODS:
Peripheral blood samples were taken from 10 normal and 10 allergic asthmatic subjects. GLP-1R expression was measured on eosinophils and neutrophils. Subsequently, the asthmatic subjects underwent allergen and diluent inhalation challenges, and GLP-1R expression was measured. Purified eosinophils, collected from mild asthmatic subjects, were stimulated with lipopolysaccharide (LPS) and a GLP-1 analog to evaluate eosinophil cell activation markers CD11b and CD69 and cytokine (IL-4, IL-5, IL-8 and IL-13) production.

RESULTS:
Glucagon-like peptide-1 receptor is expressed on human eosinophils and neutrophils. Eosinophil, but not neutrophil, expression of GLP-1R is significantly higher in normal controls compared to allergic asthmatics. The expression of GLP-1R did not change on either eosinophils or neutrophils following allergen challenge. A GLP-1 analog significantly decreased the expression of eosinophil-surface activation markers following LPS stimulation and decreased eosinophil production of IL-4, IL-8 and IL-13, but not IL-5.

CONCLUSION AND CLINICAL RELEVANCE:
Glucagon-like peptide-1 receptor is expressed on human eosinophils and neutrophils. A GLP-1 analog attenuates LPS-stimulated eosinophil activation. GLP-1 agonists may have additional adjunctive indications in treating persons with concomitant type 2 diabetes mellitus and asthma.
Original languageEnglish
Article numberPMID: 27928844
Pages (from-to)331-338
JournalClinical and Experimental Allergy
Volume47
Issue number3
Early online date28 Jan 2017
DOIs
Publication statusPublished - 2017

Fingerprint

Dive into the research topics of 'Glucagon-like peptide-1 receptor expression on human eosinophils and its regulation of eosinophil activation'. Together they form a unique fingerprint.

Cite this